Medication Oral Medications Symptom Management Innovative Therapies Medications Cancer Treatment Clinical Trials Medication Adherence Insulin Therapy Surgery Drug Efficacy Antibiotics Supportive Care Drug Therapies Disease Management Cost Considerations Alternative Therapies Immunotherapy Gene Therapy Risks CPAP Machines Lesion Recovery Amoebic Meningoencephalitis Therapeutic Approaches Therapies Efficacy and Tolerability Chronic Conditions Pharmacotherapy Research Needs Clinical Outcomes Chemotherapy Antibiotic Treatment Systemic Corticosteroids Non-Opioid Treatments Therapeutic Innovations Antimicrobial Agents Personalized Medicine Self-Administered Treatments Patient Trials Standard of Care Biologic Therapies Food Allergy Treatments Experimental Treatments Surgery and Chemotherapy Experimental Therapies Chronic Pain Medication Access Disease Progression Seizure Management Advanced Cancer Stereotactic Radiosurgery Medication Management Individualized Management Oncology Treatments Therapeutics Complications Artificial Tears Monitoring Expanded Access Programs Therapeutic Advances Antibiotics and Anti-Inflammatory Medicines Laughter Therapy Gene Therapy Infection Management Surgery for Heart Defects
Want to see what podcasts are saying about this topic? Search across 130K+ podcasts. Explore Radar
The phase 1/2 STEM-PD report shows no serious cell-related harms and early signs of graft survival while investigators plan longer follow-up and larger studies.
